CEOs of front-line Indian pharma firms deliberated at a recent summit some of the key trends set to define the future of the industry, including digitization and automation of operations, new modalities and tackling the "great talent reshuffle." (See Side Box)
With the pandemic having accelerated digitization across the sector, most Indian drug makers now appear to have a clear
“Touchless” factories is where things are going, declared Cipla Limited's global CEO and managing director Umang Vohra at the recent Global Pharmaceutical Quality Summit organized by
